China's GDP expanded 4.8% year-on-year in the July to September quarter, according to the latest data from the National ...

Gold prices were higher in early European trading on Monday, recovering some ground after a steep drop last week from record ...

U.S. President Donald Trump reiterated on Sunday that Indian Prime Minister Narendra Modi told him India will stop buying ...

The average price of property coming to market rose by 0.3% or £1,165 this month, hitting £371,422, according to Rightmove ...

As UK budget day edges closer, the persistent chatter about tax hikes is growing ever-louder. Chancellor Rachel Reeves has ...

Vietnam is split between two visions: the rumbling, reliable gas-powered motorbikes that now rule the roads, and sleek, ...

Anthony Albanese is due to meet with Trump at around 11 a.m. in Washington and will aim to use the sit down to secure an ...

Donald Trump accused Colombian President Gustavo Petro of being an “illegal drug leader,” saying the US will halt all aid to ...

Shares of Oklo (OKLO) have caught the attention of some investors lately, with the stock showing a 21% rise over the past month. This performance has sparked questions about what is driving the move ...

If you're keeping an eye on Leidos Holdings and wondering whether now is the right time to make your move, you're not alone. The stock has powered its way up an impressive 28.8% so far this year, a ...

ASML Holding’s stock narrative has shifted following a series of analyst upgrades, with the consensus price target rising sharply from approximately €809 to €938. This significant increase comes amid ...

Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression free survival (mPFS) compared to 11.0 months mPFS with pembrolizumab alone; study narrowly missed progression ...